Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease
Stefania Grimaudo(University of Palermo), Salvatore Petta(Department of Health), Rosaria Maria Pipitone(University of Palermo), Giulio Marchesini(University of Bologna), V. Di Marco(University of Palermo), Maria Rosa Barcellona(University of Palermo), Federica Spatola(University of Palermo), Grazia Pennisi(University of Palermo), Aurora Giannetti(University of Palermo), Marco Enea(University of Palermo), Roberta Boemi(University of Palermo), Calogero Cammà(University of Palermo), Antonio Craxı̀(University of Palermo), Ciro Celsa(Hammersmith Hospital)
Cited by 152
Related Papers
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
|Hepatology|2003|2.7k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821